Ledger.Open graph →
SEC Form D · filed October 26, 2018

Kato Pharmaceuticals, Inc

Offering
$8.0M
Sold
$8.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LAGUNA HILLS, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Hugh C. Neuharth · Laguna Hills, CAExecRyan Shear · Miami, FLExecTerrance S. Mcgovern · Laguna Hills, CAExec · DirectorMauro B. Bove · Laguna Hills, CADirectorOlav B. Berghein · Laguna Hills, CADirectorJosh Dolgin · Deerfield, ILExecTerrance S. Mcgovern · Laguna Hills, CAExec · DirectorMauro B. Bove · Laguna Hills, CADirectorOlav B. Berghein · Laguna Hills, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗